Lincotek Group, parent of Lincotek Medical and supplier of surface solutions and coatings equipment, global integrated supply chain services and additive manufacturing solutions for medical and other markets, signed an agreement for The Equity Club to become a minority shareholder into its share capital. The deal will provide Lincotek more than €200 million (~USD $243 million) in investment capacity.
The transaction is expected to close by March 2021. The majority of the cash will be provided through a capital increase.
Proceeds will support Lincotek’s M&A strategy and the extension of its international footprint, expanding its technology and service portfolio and becoming a fully integrated supplier for key clients in relevant industries globally.
Italy-based Lincotek supports 16 production facilities across Europe, North America and Asia.
Winfried Schaller, CEO of the Lincotek Group, said, "This is another very important step in our globalization strategy. Following several acquisitions in the last two years and the rebranding of the Group to Lincotek, the combination of the entrepreneurial spirit and drive of the [majority shareholder] Antolotti family and the experience and long-term orientation of The Equity Club will give Lincotek another boost in terms of our growth. Lincotek, as an agile global technical leader in specific niche markets, has huge potential for bolt-on acquisitions and customer-dedicated supply chain solutions, that would complete our portfolio in terms of technologies, services and geography and align with the needs of our global customer base."
Since early 2020, Lincotek has
- Finalized rebranding activities;
- Grown its coating capacity in China;
- Completed an Additive Production Center in Italy for medical applications;
- Invested in new equipment;
- Further increased implant coating capacity in Italy, and
- Brought casting and finishing into one facility in the U.S.